Streptococcus bacteriophage (ATCC® 21597-B1)

Type Strain: no  /  Biosafety Level: 1

Permits And Restrictions

View Permits

Deposited As Streptococcus phage
Induction of lytic enzyme in Streptococcus sp. Group C
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Preceptrol® no
Type Strain no
Name of Depositor Chugai Pharm. Co., Ltd.
U.S. Patent Number
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished.
Chain of Custody
ATCC <<--Chugai Pharm. Co., Ltd.<<--M. Yoshioka <<--- F. Egami <<--- W. Maxted

Ogawa H, et al. Method of production of anti-tumor substances. US Patent 3,786,141 dated Jan 15 1974

J. Biochem. 57: 64-74, 1965.

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation